IL6 and amyotrophic lateral sclerosis: Neuroinflammation is a key pathophysiological feature in ALS, and inflammatory biomarkers such as IL-6, TNF-α, IL-1, and CRP have been extensively studied (Belge et al., 2002; Berry et al., 2019; Bowser et al., 2024; Witzel et al., 2022).